Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erkan Kaba

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Turk Gogus Kalp Damar Cerrahisi Dergisi|January 31, 2022
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer centerNaziye Ak, Alper Toker, Murat Kara, et al.
Scientific Reports|September 30, 2025
Prognostic value of systemic inflammation markers in early stage non-small cell lung cancerTevfik Ilker Akcam, Ahmet Kayahan Tekneci, Kutsal Turhan, et al.
Tuberkuloz Ve Toraks|November 12, 2019
Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA)Neslihan Özçelik, Nimet Aksel, Yılmaz Bülbül, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Turk Gogus Kalp Damar Cerrahisi Dergisi|January 31, 2022
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer centerNaziye Ak, Alper Toker, Murat Kara, et al.
Scientific Reports|September 30, 2025
Prognostic value of systemic inflammation markers in early stage non-small cell lung cancerTevfik Ilker Akcam, Ahmet Kayahan Tekneci, Kutsal Turhan, et al.
Tuberkuloz Ve Toraks|November 12, 2019
Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA)Neslihan Özçelik, Nimet Aksel, Yılmaz Bülbül, et al.
Pageof 4